Researchers at Mayo Clinic identified an “exaggerated treatment effect” in more than one-third of early-phase clinical trials designed to evaluate treatments and devices for cancer and other chronic conditions.
“This phenomenon of exaggerated early results was present in a whopping 37% of the studies we reviewed,” Fares Alahdab, MD, research fellow in Mayo Clinic’s Evidence-Based Practice Center, said in a press release. “Physicians and patients should be cautious about new or early clinical trial evidence.”
Nearly 51% of the U.S. adult population has
Original Article: ‘Exaggerated’ early clinical trial results may create false hope